Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in colchicine-resistant familial Mediterranean fever in China
CTR20243346Phase 4Active
- Sponsor
- Sobi
- Start
- Sep 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of anakinra in Familial Mediterranean fever (FMF), sponsored by Sobi. Started Sep 2024; status: active.
02
Drugs
anakinra
03
Conditions
Familial Mediterranean fever (FMF)
Beyond the preview
Go deeper on CTR20243346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243346.